≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Shock, not elsewhere classified

MESH Endpoint Browser

R18_SHOCK_NOT_ELSEW_CLASSIFIED

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — R57
  • Cause of death: ICD-10 — R57

2 out of 7 registries used, show all original rules.

345

4. Check minimum number of events

None

345

5. Include endpoints

None

345

6. Filter based on genotype QC (FinnGen only)

345

Control definitions (FinnGen only)

Control exclude
R18_GENERAL_SYMPTOMS_SIGNS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
R[5-6]
Name in latin
Plaga non alibi classificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 345 138 207
Unadjusted period prevalence (%) 0.07 0.05 0.09
Median age at first event (years) 65.25 61.81 67.54

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
302
Matched controls
3021
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R57.0
ICD-10 Finland
Cardiogenic shock
+∞
139.7
123
*
R57.9
ICD-10 Finland
Shock, unspecified
+∞
72.9
67
*
R57.1
ICD-10 Finland
Hypovolaemic shock
+∞
71.8
66
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
8.9
55.2
140
267
R57.8
ICD-10 Finland
Other shock
+∞
52.7
49
*
WX872
NOMESCO Finland
Intensive care
12.9
40.5
75
75
N17.9
ICD-10 Finland
Acute renal failure, unspecified
17.4
34.4
55
38
TPH07
NOMESCO Finland
Cathetrisation of artery
6.6
31.5
91
186
A41.9
ICD-10 Finland
Sepsis, unspecified
15.2
29.1
49
38
C03CA01
ATC
furosemide; systemic
4.0
27.7
156
632
R55
ICD-10 Finland
Syncope and collapse
22.7
26.4
38
19
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.9
25.9
80
174
R50.9
ICD-10 Finland
Fever, unspecified
12.4
25.1
46
43
ZXD05
NOMESCO Finland
Urgent procedure
3.8
24.0
139
559
AA1AD
NOMESCO Finland
CT of head and brain
4.1
22.6
105
346
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
4.4
22.0
93
279
TK800
NOMESCO Finland
Hemodialysis
19.3
21.9
33
19
R56.8
ICD-10 Finland
Other and unspecified convulsions
+∞
21.1
20
*
C07AB07
ATC
bisoprolol; oral
3.2
20.6
188
1025
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.0
20.1
59
118
WX892
NOMESCO Finland
Monitored bed care
6.8
19.9
52
89
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.2
19.8
87
268
WX704
NOMESCO Finland
Intubation
6.8
19.0
50
86
I50.9
ICD-10 Finland
Heart failure, unspecified
4.1
18.8
82
250
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.1
18.3
81
249
TPH04
NOMESCO Finland
Cathetrisation of vein
3.7
17.4
90
312
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.3
17.3
110
451
C03DA01
ATC
spironolactone; oral
4.5
17.2
66
176
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.2
16.9
112
469
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
16.0
108
456
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.3
15.9
43
77
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.2
15.8
102
418
B01AA03
ATC
warfarin; systemic
3.2
15.7
99
398
I50.0
ICD-10 Finland
Congestive heart failure
5.0
15.6
53
124
C09AA05
ATC
ramipril; oral
2.9
14.9
111
498
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
5.2
14.5
46
100
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.1
14.4
47
105
N17.8
ICD-10 Finland
Other acute renal failure
23.7
14.4
20
9
JAH00
NOMESCO Finland
Laparotomy
10.5
14.0
27
28
L04AA06
ATC
mycophenolic acid; systemic
21.3
14.0
20
10
ZX120
NOMESCO Finland
Intravenous
4.7
13.8
49
120
R53
ICD-10 Finland
Malaise and fatigue
4.1
13.2
54
152
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
4.9
13.1
44
102
FXG00
NOMESCO Finland
Insertion and use of IABP
52.4
13.0
15
*
127
Kela drug reimbursment
Transplant complication
21.2
12.6
18
9
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
12.6
103
478
TK810
NOMESCO Finland
Hemofiltration
135.4
12.5
13
*
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
135.4
12.5
13
*
Z3226
NOMESCO Finland
Physiotherapist
3.1
12.2
76
297
I50.1
ICD-10 Finland
Left ventricular failure
5.3
12.1
37
77
WX882
NOMESCO Finland
High dependency care
9.6
12.0
24
27
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
48.7
12.0
14
*
J15.8
ICD-10 Finland
Other bacterial pneumonia
48.7
12.0
14
*
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
11.2
12.0
22
21
201
Kela drug reimbursment
Chronic cardiac insufficiency
4.9
12.0
40
92
Z3231
NOMESCO Finland
Registered nurse
2.6
11.9
104
501
ZXE40
NOMESCO Finland
More than seven and less than nine hours
10.7
11.7
22
22
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.0
11.5
48
137
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.9
11.2
47
135
A28
ICPC
Limited function/disability NOS
3.2
11.0
62
225
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.6
11.0
101
496
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
10.8
143
846
WW502
NOMESCO Finland
Autotransfusion
22.4
10.8
15
7
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
9.0
10.7
22
26
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
5.7
10.6
30
57
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
5.1
10.5
33
71
FXE00
NOMESCO Finland
Use of ECLA
113.8
10.5
11
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
7.1
10.4
25
38
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.5
10.3
30
59
R4110
NOMESCO Finland
Physiotherapy
2.5
10.2
96
474
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.8
10.1
28
52
AN1
HP
Coronary angiography
3.1
9.9
58
214
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
7.2
9.8
23
34
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.5
9.8
86
409
205
Kela drug reimbursment
Chronic hypertension
2.3
9.7
115
637
Z2221
NOMESCO Finland
Medical doctor
2.4
9.6
93
465
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
103.1
9.5
10
*
I42.0
ICD-10 Finland
Dilated cardiomyopathy
8.7
9.2
19
23
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
12.0
9.2
16
14
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
9.1
65
273
C01BD01
ATC
amiodarone; systemic
7.8
9.1
20
27
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
9.1
38
109
1CX08
NOMESCO Finland
NA
37.9
9.1
11
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
9.0
49
170
J01FF01
ATC
clindamycin; systemic
2.4
8.9
87
433
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
9.0
8.9
18
21
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
9.9
8.9
17
18
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.0
8.9
54
205
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.4
8.9
26
52
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
4.3
8.8
32
81
I25.2
ICD-10 Finland
Old myocardial infarction
3.4
8.8
42
135
C10AA01
ATC
simvastatin; oral
2.1
8.8
148
949
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.3
8.7
44
148
H02AB06
ATC
prednisolone; systemic
2.1
8.6
139
873
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
8.5
116
677
ZXD00
NOMESCO Finland
Emergency procedure
5.8
8.5
23
42
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
4.5
8.5
29
69
C01DA14
ATC
isosorbide mononitrate; oral
2.5
8.4
71
327
E87.2
ICD-10 Finland
Acidosis
+∞
8.4
8
*
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
+∞
8.4
8
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
8.2
35
102
A02BC02
ATC
pantoprazole; systemic
2.0
8.2
188
1349
GBB00
NOMESCO Finland
Tracheostomy
12.2
8.2
14
12
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
12.2
8.2
14
12
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.2
8.1
42
143
TKC20
NOMESCO Finland
Catheterisation of bladder
3.3
8.1
40
132
JN4AD
NOMESCO Finland
Body CT examination
3.7
8.1
35
104
Z2446
NOMESCO Finland
Social worker
4.6
8.1
27
63
TQW11
NOMESCO Finland
Vacuum treatment of wound
13.5
7.9
13
10
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.8
7.9
16
19
WX725
NOMESCO Finland
Noninvasive ventilation
5.3
7.9
23
46
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
15.5
7.8
12
8
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.9
7.7
31
86
R51.80
ICD-10 Finland
Headache
4.7
7.7
25
57
A11CC03
ATC
alfacalcidol; systemic
9.2
7.6
15
17
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
8.0
7.5
16
21
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
7.5
42
151
FXL00
NOMESCO Finland
Insertion and use of extra-, para- or intracorporeal VAD
82.0
7.4
8
*
R11
ICD-10 Finland
Nausea and vomiting
4.0
7.4
29
79
B03XA02
ATC
darbepoetin alfa; parenteral
9.7
7.4
14
15
Z94.1
ICD-10 Finland
Heart transplant status
+∞
7.3
7
*
I95.9
ICD-10 Finland
Hypotension, unspecified
16.2
7.3
11
7
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
7.3
31
91
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
7.3
73
365
R4130
NOMESCO Finland
Speech therapy
8.2
7.2
15
19
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.1
7.2
27
71
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
20.6
7.2
10
5
G04BE03
ATC
sildenafil; oral
10.4
7.1
13
13
I21.09
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
7.3
7.1
16
23
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
14.2
6.9
11
8
C09DX04
ATC
valsartan and sacubitril; oral
14.2
6.9
11
8
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
6.9
29
84
I20.90
ICD-10 Finland
Angina pectoris, unspecified
5.3
6.9
20
40
I21.01
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
6.4
6.9
17
28
PD5BD
NOMESCO Finland
Extensive CT of aorta
9.6
6.9
13
14
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
6.8
55
246
JN4BD
NOMESCO Finland
Extensive body CT
2.9
6.8
40
149
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
6.7
42
162
K72.9
ICD-10 Finland
Hepatic failure, unspecified
23.1
6.7
9
*
Z94.0
ICD-10 Finland
Kidney transplant status
23.1
6.7
9
*
C01AA05
ATC
digoxin; systemic
2.8
6.7
45
180
B01AB05
ATC
enoxaparin; parenteral
2.0
6.6
94
547
J01MA02
ATC
ciprofloxacin; systemic
1.9
6.6
119
759
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.9
6.6
26
72
WX730
NOMESCO Finland
Conventional respirator
7.7
6.5
14
19
R06.0
ICD-10 Finland
Dyspnoea
2.1
6.4
77
416
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.0
6.3
24
64
G72.8
ICD-10 Finland
Other specified myopathies
9.6
6.3
12
13
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
3.3
6.3
30
97
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
18.5
6.3
9
5
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
18.5
6.3
9
5
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.1
6.3
80
445
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.7
6.3
41
164
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
+∞
6.3
6
*
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
27.3
6.3
8
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.6
6.3
17
32
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.4
6.2
28
87
J01MA14
ATC
moxifloxacin; systemic
3.1
6.2
32
110
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.0
6.1
23
61
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.9
6.1
12
14
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.4
6.1
17
33
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.9
6.1
14
21
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.0
6.1
85
489
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
5.0
6.0
18
38
I20.99
ICD-10 Finland
Angina pectoris, unspecified
3.3
6.0
29
95

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
120
200
8.67
74.66
21.0
6.3
mmol/l
11.8
10.6
0.70
115
189
(3003458) Phosphate [Moles/volume] in Serum or Plasma
130
280
6.85
62.44
15.1
5.7
mmol/l
1.1
1.1
0.39
124
258
(3027801) Oxygen [Partial pressure] in Arterial blood
123
262
6.74
59.46
34.4
6.8
kpa
12.0
12.2
0.16
111
252
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
123
262
6.74
59.46
34.4
6.8
kpa
4.8
5.1
2.07
111
251
(3003396) Base excess in Arterial blood by calculation
122
259
6.74
59.15
34.7
6.9
mmol/l
0.8
1.2
0.32
87
207
(3007930) Methemoglobin/Hemoglobin.total in Blood
76
98
9.66
57.68
36.3
5.4
%
1.1
0.9
1.57
69
93
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
77
104
9.24
56.26
35.7
5.2
%
1.8
1.6
0.81
69
98
(3012095) Magnesium [Moles/volume] in Serum or Plasma
139
350
5.98
55.85
11.4
2.8
mmol/l
0.8
0.8
0.06
132
329
(3047181) Lactate [Moles/volume] in Blood
61
69
10.52
50.88
46.1
6.4
mmol/l
1.9
1.2
2.87
54
62
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
78
123
7.90
49.69
49.5
8.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
69
95
8.83
49.36
4.7
1.5
ug/l
13.4
2.6
1.48
62
81
(3039000) Anion gap in Blood
54
54
11.67
49.05
50.1
6.8
mmol/l
12.8
11.0
1.85
48
49
(3018572) Chloride [Moles/volume] in Blood
54
54
11.67
49.05
50.1
6.8
mmol/l
106.5
105.3
0.88
48
49
(3016502) Oxygen saturation in Arterial blood
108
242
6.04
48.64
38.3
7.1
%
96.2
95.3
0.56
100
236
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
58
69
9.90
46.46
9.6
2.3
u/ml
0.3
0.4
0.79
45
34
(3008152) Bicarbonate [Moles/volume] in Arterial blood
80
145
6.88
44.53
39.7
7.6
mmol/l
23.3
24.6
1.37
73
136
(3002173) Hemoglobin [Mass/volume] in Arterial blood
99
222
5.85
44.21
41.6
7.5
g/l
110.2
119.3
3.30
93
213
(3004789) Transferrin [Mass/volume] in Serum or Plasma
115
313
5.01
40.77
4.3
2.1
g/l
2.2
2.3
1.72
109
287
(3023368) Bacteria identified in Blood by Culture
169
634
4.26
39.07
9.4
3.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
77
162
5.83
36.40
37.8
4.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
106
296
4.73
35.96
4.4
2.2
%
20.2
22.5
0.76
76
250
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
129
433
4.16
34.08
8.5
3.1
ng/l
814.6
482.6
0.58
118
354
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
89
229
4.89
33.21
2.2
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
88
232
4.75
31.77
2.1
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
90
245
4.62
31.16
8.8
3.4
u/l
267.0
251.7
0.28
84
229
(3023419) Bacteria identified in Sputum by Culture
30
25
13.05
30.26
2.1
3.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
107
339
4.13
30.20
5.2
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
82
218
4.62
29.12
7.9
4.0
mmol/l
1.5
1.9
0.38
68
171
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
68
155
5.22
29.08
2.9
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
203
1013
3.44
28.03
20.8
7.9
inr
1.3
1.3
0.03
43
263
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
103
346
3.82
26.39
2.3
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
154
671
3.34
26.21
4.3
3.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
24
12.12
26.09
10.4
8.9
iu/ml
547.8
127.8
—
5
5
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
38
56
7.50
25.15
9.0
2.2
%
234.2
182.3
1.94
38
56
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
51
102
5.69
25.08
2.4
1.5
g/l
1.6
1.4
0.50
42
85
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
36
9.36
24.91
1.3
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
102
357
3.64
24.38
9.4
1.9
s
33.6
29.6
3.00
102
343
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
30
10.07
23.84
2.1
1.3
u/ml
274.8
98.3
—
7
6
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
30
36
9.03
23.48
1.3
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
74
216
4.09
22.90
2.8
2.3
ug/l
18.1
8.0
1.37
63
187
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
71
202
4.17
22.74
4.1
2.2
g/l
0.2
0.2
1.96
63
191
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
32
9.43
22.73
2.1
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
33
48
7.50
22.04
13.2
4.8
—
—
—
0
0
(44806118)
21
17
13.09
21.38
1.3
1.4
—
—
—
0
0
(44790048)
21
17
13.09
21.38
1.3
1.4
—
—
—
0
0
(44790049)
21
17
13.09
21.38
1.3
1.4
—
—
—
0
0
(44790047)
21
17
13.09
21.38
1.3
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
86
295
3.55
20.92
19.4
6.3
mmol/l
104.5
104.5
0.04
86
288
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
202
1131
2.90
20.68
32.9
6.2
mmol/l
1.2
1.2
8.72
182
950
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
213
1229
2.92
20.56
16.5
5.4
umol/l
15.2
11.9
2.17
206
1153
(3024561) Albumin [Mass/volume] in Serum or Plasma
184
993
2.83
20.01
15.2
4.6
g/l
30.9
35.3
13.84
174
924
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
130
591
2.93
19.47
3.2
1.9
mg/l
2.8
3.1
0.41
118
497
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
154
766
2.83
19.47
8.4
3.2
u/l
58.3
31.7
1.01
146
733
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
140
678
2.79
18.43
4.0
1.8
u/l
577.4
262.1
1.42
132
632
(3014111) Lactate [Moles/volume] in Serum or Plasma
64
196
3.78
18.29
21.0
6.4
mmol/l
2.2
1.4
1.84
57
189
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
143
705
2.76
18.12
5.9
2.1
u/l
64.5
57.8
0.67
137
650
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
75
259
3.42
17.85
6.9
2.4
umol/l
10.9
9.4
0.28
67
229
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
42
6.89
16.90
1.9
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
30
8.14
16.75
1.8
1.2
u/ml
235.8
254.0
0.09
17
17
(3000991) Gas panel - Venous blood
61
192
3.64
16.68
25.9
6.8
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
46
119
4.31
16.52
26.1
8.0
mmol/l
22.3
24.8
3.15
40
107
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
15
11.87
16.32
1.4
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
31
7.88
16.30
1.8
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
73
262
3.27
16.23
2.5
2.5
%
1.9
1.7
0.46
66
236
(3001122) Ferritin [Mass/volume] in Serum or Plasma
170
958
2.53
15.88
4.3
2.3
ug/l
210.5
146.3
1.89
162
880
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
53
5.88
15.52
2.9
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
186
1102
2.49
15.47
9.6
3.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
220
1409
2.55
15.43
25.3
4.1
mmol/l
7.8
6.8
4.11
207
1307
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
10
14.55
15.12
1.3
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
141
745
2.51
14.91
10.3
5.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
179
1057
2.44
14.80
32.6
5.2
mmol/l
1.2
1.2
8.35
168
941
(3018010) Neutrophils/100 leukocytes in Blood
181
1089
2.39
14.15
11.4
4.9
%
61.0
57.3
3.41
176
1023
(3002030) Lymphocytes/100 leukocytes in Blood
181
1097
2.37
13.81
11.5
5.1
%
22.8
27.7
5.94
174
1020
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
100
463
2.63
13.78
8.4
1.6
mg/l
3.1
1.3
1.69
87
359
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
44
5.79
12.77
1.3
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
55
191
3.24
12.77
2.8
2.5
e9/l
69.1
66.7
0.16
47
148
(3007853) Bacteria identified in Skin by Aerobe culture
69
274
2.90
12.70
2.7
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
170
1036
2.26
12.41
11.0
5.0
%
0.6
0.6
0.50
165
966
(3021901) Oxygen saturation in Capillary blood
21
35
6.32
12.27
2.9
2.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
59
219
3.04
12.22
1.9
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
29
6.88
12.04
1.1
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
132
732
2.30
12.00
4.7
2.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
56
4.94
11.62
4.2
2.7
nmol/l
1.1
1.0
0.26
21
47
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
27
6.98
11.58
1.1
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
16
8
20.89
11.23
4.1
1.0
%
87.9
116.1
—
16
8
(3019198) Lymphocytes [#/volume] in Blood
181
1165
2.16
11.17
11.2
4.8
e9/l
1.7
1.9
0.82
162
1036
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
19
8.21
11.09
1.5
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
14
9.61
10.83
1.1
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
120
663
2.24
10.81
9.8
3.5
ph
7.4
7.4
0.44
21
120
(3006315) Basophils [#/volume] in Blood
176
1139
2.11
10.50
11.0
4.8
e9/l
0.0
0.0
0.11
159
996
(3021879) Hepatitis B virus core Ab [Presence] in Serum
42
139
3.30
10.49
1.5
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
175
1132
2.11
10.44
11.0
4.7
e9/l
0.7
0.6
3.45
158
983
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
15
8.97
10.29
2.2
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
21
7.42
10.21
1.1
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
179
1176
2.09
10.15
11.6
5.1
e9/l
0.2
0.2
0.29
162
1045
(3022217) INR in Platelet poor plasma by Coagulation assay
68
303
2.55
9.87
32.9
28.4
inr
1.8
1.4
—
7
36
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
59
253
2.61
9.23
1.9
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
89
463
2.24
9.08
1.9
1.7
nmol/l
1007.2
1207.3
1.57
73
357
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
50
200
2.75
8.96
3.2
1.9
u/l
29.2
30.7
0.13
44
168
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
56
4.33
8.86
1.5
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
19
7.07
8.50
1.2
2.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
20
45
4.66
8.48
1.2
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
16
7.73
8.46
3.1
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
18
37
5.08
8.46
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
88
470
2.17
8.34
4.5
2.5
mosm/kgh2o
544.4
584.4
0.99
82
395
(3013650) Neutrophils [#/volume] in Blood by Automated count
190
1346
1.92
8.01
14.3
7.8
e9/l
5.1
4.2
3.10
174
1180
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
123
757
1.97
7.89
8.7
3.0
ng/l
4625.5
1494.2
3.06
117
642
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
149
979
1.92
7.86
2.5
1.9
pmol/l
86.0
93.8
1.09
91
511
(3002582) Erythrocytes [#/volume] in Urine
119
727
1.97
7.78
4.6
2.9
e6/l
79.5
160.5
0.41
97
573
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
22
58
3.98
7.65
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
50
4.18
7.45
1.5
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
96
556
2.01
7.23
4.5
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
13
7.89
7.15
1.4
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
61
298
2.27
7.12
1.9
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
143
2.78
7.05
6.5
3.5
mmol/l
0.5
1.6
0.69
24
113
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
240
1879
1.91
7.01
18.3
6.4
u/l
92.7
77.7
4.43
233
1735
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
53
3.94
6.91
1.5
1.2
ug/g
250.3
261.5
0.08
14
26
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
24
5.59
6.82
1.4
1.2
u/ml
1.8
2.1
—
6
8
(3000494) Fungus identified in Specimen by Culture
57
277
2.27
6.72
3.1
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
105
642
1.91
6.69
4.4
2.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
33
4.71
6.52
1.1
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
37
150
2.64
6.44
6.7
3.4
ph
7.4
7.4
—
5
12
(3037467) Urinalysis macro (dipstick) panel - Urine
218
1681
1.81
6.39
5.9
3.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
119
771
1.83
6.26
6.4
3.2
mmol/l
2.3
2.3
3.83
107
666
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
69
375
2.05
6.11
2.9
2.7
e6/l
3.5
1.2
0.65
38
223
(3023199) Leukocytes [#/volume] in Pleural fluid
15
35
4.44
6.08
1.5
1.2
e6/l
770.6
1998.7
—
10
28
(3024471) HLA-A [Type]
9
6
15.35
5.93
1.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
6
15.35
5.93
1.1
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
6
15.35
5.93
1.1
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
6
15.35
5.93
1.1
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
36
4.31
5.88
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
36
4.31
5.88
1.2
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
9
11.40
5.83
1.2
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
129
875
1.76
5.73
4.7
2.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
46
3.84
5.71
1.3
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
17
6.03
5.66
1.2
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
7
13.15
5.61
3.0
1.0
%
149.7
139.3
—
9
7
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
29
112
2.74
5.55
4.3
3.2
%
0.8
0.6
1.11
29
107
(3037756) Immunofixation for Serum or Plasma
16
43
3.85
5.43
2.3
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
103
664
1.79
5.39
4.6
2.9
e6/l
0.5
0.5
0.00
82
504
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
8
11.51
5.32
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
26
4.75
5.30
1.5
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
22
5.13
5.29
1.7
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
22
5.13
5.29
5.5
2.5
e9/l
4.5
4.5
0.03
11
22
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
75
3.07
5.24
3.5
2.1
g/l
3.1
3.1
0.04
16
57
(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid
5
0
+∞
5.22
1.2
0.0
umol/l
82.0
—
—
5
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
135
2.51
5.15
1.7
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
31
4.32
5.13
1.5
1.2
e6/l
3396.4
46822.7
—
7
21
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
31
4.32
5.13
1.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
123
2.58
5.12
2.5
2.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
6
13.61
5.10
1.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
6
13.61
5.10
1.1
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
27
4.57
5.07
2.0
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
23
4.91
5.05
6.5
2.7
%
59.9
58.5
0.09
11
23
(40767503) Oxygen content in Capillary blood by calculation
15
41
3.78
4.98
3.9
1.9
%
16.2
15.7
—
10
19
(3018095) Leukocytes [#/volume] in Urine
123
855
1.68
4.84
5.3
3.3
e6/l
74.5
67.8
0.08
100
621
(3037522) Nuclear Ab [Titer] in Serum
50
263
2.05
4.81
1.5
1.3
titre
312.0
360.7
—
10
56
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
20
5.12
4.80
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
20
5.12
4.80
1.6
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
33
4.05
4.75
2.8
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
33
4.05
4.75
1.2
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
74
2.96
4.74
3.7
1.9
g/l
11.0
10.3
0.24
16
64
(1616796) Gas panel - Central venous blood
15
43
3.60
4.66
7.7
3.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
118
2.49
4.53
1.8
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
82
2.80
4.51
3.5
2.0
g/l
7.6
7.2
0.46
16
61
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
82
2.80
4.51
3.5
2.0
g/l
3.9
3.8
0.02
16
56
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
82
2.80
4.51
3.5
2.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
30
134
2.36
4.29
3.4
2.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
6
11.87
4.29
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
23
4.45
4.11
1.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
66
404
1.78
4.02
2.7
2.6
e6/l
1.1
1.1
0.07
34
252
(3052851) Hemolysis interference index of Serum or Plasma
18
64
2.91
4.02
5.2
2.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
131
961
1.59
4.01
5.7
3.2
ng/l
668.1
85.4
1.19
103
689
(3021589) Normoblasts [#/volume] in Blood
141
1053
1.57
3.99
18.3
8.1
e9/l
0.0
0.0
0.08
121
880
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
38
3.52
3.94
1.8
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
85
562
1.68
3.94
12.7
6.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
91
615
1.65
3.87
4.9
2.5
umol/l
3034.2
8519.0
0.87
86
530
(3017181) Myelocytes/100 leukocytes in Blood
35
175
2.11
3.85
4.4
3.5
%
0.7
0.9
—
10
53
(40760892) CBC W Ordered Manual Differential panel - Blood
74
474
1.71
3.85
7.6
3.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
14
44
3.27
3.82
5.5
3.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
124
907
1.57
3.80
3.6
2.1
nmol/l
71.7
76.3
1.02
112
797
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
5
12.18
3.77
1.5
1.0
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
6
5
12.18
3.77
3.0
1.8
umol/l
1.2
2.0
—
6
5
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
15
50
3.09
3.73
3.7
1.3
nmol/l
0.6
0.8
1.04
15
45
(4306422)
10
25
4.09
3.72
1.7
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
12
6.79
3.69
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
9
7.91
3.57
2.9
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
31
154
2.11
3.48
4.5
3.3
%
1.0
0.3
—
7
35
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
27
3.78
3.38
1.2
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
46
266
1.84
3.37
4.3
4.6
ug/l
54.6
10.3
0.40
40
222
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
14
5.82
3.36
1.4
1.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
18
71
2.62
3.35
1.1
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
71
2.62
3.35
2.3
2.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
15
5.43
3.21
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
112
2.23
3.14
1.5
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
39
3.15
3.12
1.3
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
18
74
2.51
3.10
3.7
3.7
—
—
—
0
0
(3017704) Immunofixation for Urine
6
8
7.61
3.06
2.8
2.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
8
7.61
3.06
2.0
1.1
—
—
—
0
0
(4268621)
9
21
4.37
3.01
2.7
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
213
1804
1.47
3.01
5.9
3.6
mm/h
20.2
11.9
8.29
205
1642
(1761868) Lipid panel - Serum or Plasma
58
860
0.61
3.00
4.4
2.9
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
12
40
3.07
3.00
1.0
1.2
u/l
10.3
11.6
—
7
33
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
5
10.12
2.99
1.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
5
10.12
2.99
1.2
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
22
4.17
2.90
1.3
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
9
6.76
2.88
1.7
1.0
nmol/l
92.3
164.4
—
6
9
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
9
6.76
2.88
3.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
60
393
1.64
2.85
2.0
1.3
g/l
2.9
2.5
0.69
37
225
(3051611) Lipemic interference index of Serum or Plasma
9
23
3.99
2.79
5.6
2.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
9
23
3.99
2.79
1.8
1.1
%
85.2
115.3
—
9
23
(3019230) Fractional oxyhemoglobin in Venous blood
12
42
2.92
2.78
7.1
5.0
%
57.0
62.3
0.26
12
42
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
185
1540
1.43
2.77
7.5
3.0
u/l
76.1
49.7
2.70
171
1433
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
186
0.31
2.76
2.0
1.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
6
8.43
2.76
1.6
1.0
u/ml
1586.6
769.3
—
5
6
(3016879) Cocaine [Presence] in Urine
13
48
2.78
2.75
1.8
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
10
6.08
2.71
2.7
5.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
10
6.08
2.71
1.0
1.0
mmol/l
1.7
1.8
—
6
10
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
8
19
4.28
2.69
1.6
1.1
%
73.8
90.8
—
8
19
(3021440) Promyelocytes/100 leukocytes in Blood
30
163
1.92
2.67
4.9
3.7
%
0.0
0.1
—
10
48
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
206
2346
0.70
2.67
38.1
11.6
ml/min/173m2
71.3
78.0
3.21
184
1895
(3000764) Benzodiazepines [Presence] in Urine
13
49
2.72
2.65
1.8
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
207
1770
1.42
2.61
5.9
3.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
15
62
2.48
2.57
1.1
1.1
—
20.0
—
0
5
(3022313) Gas panel - Capillary blood
24
122
2.04
2.57
7.7
3.3
—
—
—
0
0
(4198724)
5
7
7.23
2.55
2.8
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
220
2467
0.70
2.50
5.4
4.5
mmol/l
1.3
1.4
4.86
205
2242
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
16
4.44
2.48
1.7
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
51
2.61
2.47
1.8
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
51
2.61
2.47
1.8
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
51
2.61
2.47
1.9
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
46
688
0.62
2.42
2.7
3.1
ug/l
0.6
0.8
1.74
30
463
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
8
6.32
2.38
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
126
1.97
2.37
3.7
3.4
—
—
—
0
0
(3035880) pH of Pleural fluid
7
17
4.18
2.37
1.3
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
18
3.95
2.26
1.6
1.1
—
—
—
0
0
(3015736) pH of Urine
115
906
1.40
2.24
3.7
3.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
145
1192
1.37
2.18
5.0
3.4
estimate
0.0
0.0
0.00
22
199
(3019150) Specific gravity of Urine by Refractometry
72
523
1.48
2.16
4.4
3.7
kg/l
1.0
1.0
0.66
17
85
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
14
4.34
2.16
1.5
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
207
0.42
2.15
1.7
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
224
2483
0.72
2.15
5.5
4.5
mmol/l
4.2
4.6
6.35
209
2282
(3035350) Ketones [Presence] in Urine by Test strip
143
1175
1.37
2.15
4.7
3.3
estimate
0.0
0.0
0.00
21
208
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
37
2.75
2.12
1.1
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
70
510
1.47
2.07
2.0
1.8
pmol/l
467.9
13380703.4
0.50
60
426
(3051651) Icteric interference index of Serum or Plasma
6
15
4.05
2.04
6.3
2.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
60
425
1.50
2.04
3.1
2.9
mmol/l
2.5
2.5
0.79
50
373
(3028707) Methadone [Presence] in Urine by Screen method
7
21
3.38
1.97
2.4
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
27
158
1.77
1.95
5.3
3.6
%
0.0
0.2
—
8
40
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
27
3.01
1.95
1.6
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
11
4.59
1.95
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
11
4.59
1.95
1.4
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
11
4.59
1.95
1.0
7.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
33
2.77
1.94
1.6
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
38
247
1.61
1.89
2.5
1.7
%
1.7
1.4
1.25
30
215
(3022621) pH of Urine by Test strip
28
169
1.71
1.83
3.8
2.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
231
2527
0.74
1.83
6.0
5.1
mmol/l
2.3
2.7
7.79
215
2300
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
53
2.31
1.82
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
35
2.61
1.81
1.2
1.7
—
—
—
0
0
(3016750) Collection duration of Urine
6
18
3.37
1.75
2.7
2.3
min
502.2
491.9
—
6
11
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
24
2.95
1.73
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
48
0.00
1.71
0.0
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
97
774
1.35
1.70
3.5
3.3
mg/l
1341.2
146.2
0.93
75
512
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
254
1.56
1.69
6.0
3.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
42
2.42
1.69
2.3
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
69
521
1.41
1.69
3.7
3.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
140
1180
1.31
1.68
6.4
4.6
estimate
0.0
0.0
0.00
20
206
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
19
3.19
1.67
1.2
1.9
—
—
—
0
0
(4035726)
31
199
1.61
1.63
2.6
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
14
3.61
1.62
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
14
3.61
1.62
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
14
3.61
1.62
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
84
661
1.36
1.60
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
101
818
1.33
1.59
4.4
4.0
mg/mmol
6.0
11.4
1.25
76
530
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
201
1790
1.29
1.56
4.4
3.4
pmol/l
14.8
15.0
0.46
185
1580
(3012441) Differential panel - Pleural fluid
8
33
2.46
1.54
1.4
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
125
0.39
1.53
1.4
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
15
3.37
1.53
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
15
3.37
1.53
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
15
3.37
1.53
1.2
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
15
3.37
1.53
1.0
5.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
218
2381
0.77
1.51
5.6
4.0
mmol/l
1.3
1.3
0.59
203
2150
(3045142) Bone marrow Pathology biopsy report
6
21
2.89
1.51
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
98
800
1.31
1.46
3.9
3.2
mmol/l
6.7
7.7
2.26
89
664
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
39
2.34
1.44
1.2
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
41
2.23
1.38
1.3
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
17
2.97
1.36
1.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
17
2.97
1.36
3.4
2.4
%
14.1
13.3
—
5
17
(3020891) Body temperature
17
98
1.77
1.33
12.9
4.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
24
2.53
1.31
2.8
3.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
15
84
1.82
1.29
2.5
3.1
g/l
0.2
0.2
—
7
34
(3011648) Oxygen content in Venous blood
5
18
2.80
1.29
2.2
9.4
%
7.3
11.7
—
5
18
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
44
2.07
1.27
1.1
1.3
—
2.5
—
0
6
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
36
2.25
1.25
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
34
0.00
1.16
0.0
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
20
2.52
1.15
1.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
20
2.52
1.15
1.6
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
23
151
1.56
1.15
1.2
1.2
—
—
—
0
0
(3010421) pH of Blood
11
58
1.93
1.13
13.5
3.3
ph
7.4
7.4
0.01
11
49
(3009542) Hematocrit [Volume Fraction] of Blood
242
2252
1.25
1.10
58.2
13.7
%
34.2
39.9
7.67
157
1585
(21494890) Protein electrophoresis panel - 24 hour Urine
5
21
2.40
1.09
2.0
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
57
450
1.32
1.08
1.3
1.2
u/ml
1.0
0.8
0.19
11
120
(3042631) Mycobacterium sp identified in Specimen
5
22
2.29
1.03
2.6
3.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
34
2.08
1.03
2.0
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
318
0.67
1.02
15.6
6.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
102
1177
0.81
1.00
4.2
5.0
ug/l
3.3
2.5
0.31
94
1042
(3048689) Calprotectin [Mass/mass] in Stool
32
234
1.41
0.98
2.2
2.3
ug/g
202.4
138.0
0.40
27
186
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
50
1.82
0.97
1.8
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
81
679
1.25
0.97
4.8
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
81
954
0.80
0.96
3.6
4.4
%
22.6
21.7
0.15
31
469
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
37
1.91
0.94
19.0
2.9
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
27
2.24
0.94
5.3
1.1
%
89.7
89.3
—
6
27
(3044927) Protein electrophoresis panel - Urine
6
28
2.16
0.92
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
111
1.56
0.89
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
232
2460
0.83
0.89
5.1
4.6
mmol/l
6.3
6.0
2.35
215
2219
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
24
0.00
0.79
0.0
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
27
0.00
0.77
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
27
0.00
0.77
0.0
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
40
317
1.30
0.76
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
159
0.62
0.74
1.6
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
143
0.62
0.71
1.6
2.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
69
1.61
0.69
1.2
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
59
1.54
0.69
1.1
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
106
945
1.18
0.68
5.0
3.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
28
1.80
0.66
3.4
1.7
pg
34.2
33.6
—
5
28
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
261
2500
1.18
0.64
46.1
11.8
mg/l
35.5
26.8
3.49
246
1931
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
71
1.57
0.63
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
43
355
1.24
0.61
1.3
1.2
u/ml
2.0
13.4
2.33
13
142
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
225
2361
0.86
0.61
8.1
5.9
mmol/mol
42.5
40.3
2.14
213
2186
(3025130) Human papilloma virus identified in Specimen
0
20
0.00
0.60
0.0
2.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.1
—
47.8
—
0
7
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
45
376
1.23
0.58
1.2
1.2
iu/ml
32.4
49.4
0.49
12
125
(3044941) Cell count panel - Synovial fluid
6
36
1.68
0.57
2.5
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
73
1.52
0.57
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
22
168
1.33
0.56
5.2
3.1
e9/l
4.6
4.2
0.26
15
130
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
19
245
0.76
0.50
1.3
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(4010399)
20
159
1.27
0.41
1.3
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.0
—
0
6
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
34
1.48
0.40
1.2
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
69
1.31
0.37
2.0
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
126
1.28
0.36
1.8
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
106
0.75
0.29
1.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
85
1.30
0.28
1.8
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
71
0.70
0.26
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
75
0.66
0.26
2.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
74
1.22
0.25
2.8
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
12
96
1.26
0.25
1.3
2.6
u/ml
96.1
44.5
0.31
12
90
(3001019) Free T4 and TSH panel - Serum or Plasma
6
83
0.72
0.24
1.8
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
39
1.29
0.23
5.8
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
116
1.22
0.22
3.2
2.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
13
107
1.22
0.22
11.5
3.7
mmol/l
23.5
24.9
0.73
13
100
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
98
1.23
0.21
1.7
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
11
0.00
0.21
0.0
5.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(4027681)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
0.9
—
0
6
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
20
229
0.87
0.20
7.6
3.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
260
2644
0.93
0.19
42.6
11.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
52
1.16
0.19
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
164
0.85
0.18
1.4
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
140
1357
1.05
0.16
3.3
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
265
1.10
0.15
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
20
222
0.89
0.14
1.5
1.5
—
—
—
0
0
(3013512) EKG study
73
760
0.95
0.12
6.6
3.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
91
941
0.96
0.11
2.3
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
318
1.08
0.11
1.4
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
46
1.09
0.09
1.2
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
21
194
1.09
0.09
8.3
3.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
61
0.82
0.08
1.0
1.8
pmol/l
118.4
235.6
—
5
56
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
67
1.05
0.08
2.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
71
0.84
0.07
1.8
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
108
1.12
0.07
1.1
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
224
2217
1.03
0.07
5.5
4.2
mu/l
2.1
2.0
0.52
211
1967
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
242
0.95
0.05
1.1
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
120
1.09
0.05
1.1
1.2
iu/ml
343.2
128.1
—
6
42
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
190
0.94
0.04
4.2
2.7
ml/min/173m2
52.9
64.4
0.89
12
65
(3002256) Pathology report gross observation
34
329
1.04
0.03
1.2
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
64
632
1.02
0.01
5.7
3.5
estimate
0.0
0.0
0.00
19
199
(3045414) Leukocytes [Presence] in Urine
10
94
1.07
0.01
2.0
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
19
192
0.99
0.00
4.7
3.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
146
1.03
0.00
1.3
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.8
1.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(4034850)
8
79
1.01
0.00
41.9
8.8
—
—
—
0
0
(4015189)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
0.2
—
0
5
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
34.6
—
0
5
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
3.3
—
0
8
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_SHOCK_NOT_ELSEW_CLASSIFIED – Shock, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).